DE69922528D1 - N-imidazolyl-alkyl substituierte cyklische amine als histamin-h3 agonisten oder antagonisten - Google Patents

N-imidazolyl-alkyl substituierte cyklische amine als histamin-h3 agonisten oder antagonisten

Info

Publication number
DE69922528D1
DE69922528D1 DE1999622528 DE69922528T DE69922528D1 DE 69922528 D1 DE69922528 D1 DE 69922528D1 DE 1999622528 DE1999622528 DE 1999622528 DE 69922528 T DE69922528 T DE 69922528T DE 69922528 D1 DE69922528 D1 DE 69922528D1
Authority
DE
Germany
Prior art keywords
histamine
cyclic amines
substituted cyclic
imidazolyl
agonists
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE1999622528
Other languages
English (en)
Other versions
DE69922528T2 (de
Inventor
Ronald Wolin
B Rosenblum
Adriano Afonso
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck Sharp and Dohme Corp
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Application granted granted Critical
Publication of DE69922528D1 publication Critical patent/DE69922528D1/de
Publication of DE69922528T2 publication Critical patent/DE69922528T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
DE69922528T 1998-10-16 1999-10-15 N-imidazolyl-alkyl substituierte cyklische amine als histamin-h3 agonisten oder antagonisten Expired - Fee Related DE69922528T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US09/173,642 US6133291A (en) 1998-10-16 1998-10-16 N-(imidazolylalkyl)substituted cyclic amines as histamine-H3 agonists or antagonists
US173642 1998-10-16
PCT/US1999/021461 WO2000023438A1 (en) 1998-10-16 1999-10-15 N-(imidazolylalkyl)substituted cyclic amines as histamine-h3 agonists or antagonists

Publications (2)

Publication Number Publication Date
DE69922528D1 true DE69922528D1 (de) 2005-01-13
DE69922528T2 DE69922528T2 (de) 2005-12-15

Family

ID=22632924

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69922528T Expired - Fee Related DE69922528T2 (de) 1998-10-16 1999-10-15 N-imidazolyl-alkyl substituierte cyklische amine als histamin-h3 agonisten oder antagonisten

Country Status (10)

Country Link
US (1) US6133291A (de)
EP (1) EP1121354B1 (de)
JP (1) JP2002527513A (de)
CN (1) CN1198817C (de)
AT (1) ATE284398T1 (de)
AU (1) AU1092800A (de)
CA (1) CA2346436A1 (de)
DE (1) DE69922528T2 (de)
ES (1) ES2229782T3 (de)
WO (1) WO2000023438A1 (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6635661B2 (en) 2000-05-25 2003-10-21 Sepracor Inc. Heterocyclic analgesic compounds and methods of use thereof
US6677332B1 (en) 1999-05-25 2004-01-13 Sepracor, Inc. Heterocyclic analgesic compounds and methods of use thereof
US7361666B2 (en) 1999-05-25 2008-04-22 Sepracor, Inc. Heterocyclic analgesic compounds and methods of use thereof
WO2001068604A2 (en) 2000-03-14 2001-09-20 Sepracor, Inc. 3-substituted piperidines comprising urea functionality, and methods of use thereof
AU2001216218A1 (en) * 2000-05-25 2001-12-11 Sepracor, Inc. Heterocyclic analgesic compounds and method of use thereof
CA2422729A1 (en) * 2000-09-20 2002-06-06 Schering Corporation Substituted imidazoles as dual histamine h1 and h3 agonists or antagonists
FR2827863A1 (fr) * 2001-07-27 2003-01-31 Sanofi Synthelabo Derives d'aminoalkylimidazole, leur preparation et leur utilisation en therapeutique
KR100432577B1 (ko) 2002-02-08 2004-05-24 주식회사유한양행 이미다졸 유도체의 제조방법
US7183305B2 (en) 2003-11-11 2007-02-27 Allergan, Inc. Process for the synthesis of imidazoles
US7880017B2 (en) 2003-11-11 2011-02-01 Allergan, Inc. Process for the synthesis of imidazoles
MX2007016523A (es) * 2005-06-20 2008-03-06 Schering Corp Piperidinas sustituidas ligadas a carbono y derivados de las mismas utiles como antagonistas de hsitamina h3.
US20100210633A1 (en) * 2006-10-12 2010-08-19 Epix Delaware, Inc. Carboxamide compounds and their use
US8569282B2 (en) 2007-12-11 2013-10-29 Cytopathfinder, Inc. Carboxamide compounds and their use
WO2013151982A1 (en) 2012-04-03 2013-10-10 Arena Pharmaceuticals, Inc. Methods and compounds useful in treating pruritus, and methods for identifying such compounds
EP3233799B1 (de) * 2014-12-19 2021-05-19 The Broad Institute, Inc. Dopamin-d2-rezeptor-liganden
US10633336B2 (en) 2014-12-19 2020-04-28 The Broad Institute, Inc. Dopamine D2 receptor ligands

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4006137A (en) * 1975-08-21 1977-02-01 E. R. Squibb & Sons, Inc. 2-Ethenyl imidazolium derivatives
ZA792608B (en) * 1978-05-30 1980-06-25 Smith Kline French Lab Nitro compounds
JPS6287573A (ja) * 1985-10-11 1987-04-22 Banyu Pharmaceut Co Ltd 四級アンモニウム塩の製造法
GB8916947D0 (en) * 1989-07-25 1989-09-13 Smith Kline French Lab Medicaments
GB9115740D0 (en) * 1991-07-20 1991-09-04 Smithkline Beecham Plc Medicaments
CA2125964C (en) * 1991-12-18 2001-06-19 Neng-Yang Shih Imidazolyl-alkyl-piperazine and -diazepine derivatives as histamine h3 agonists/antagonists
CA2129679C (en) * 1991-12-18 2000-05-09 Neng-Yang Shih Imidazolyl or imidazoylalkyl substituted with a four or five membered nitrogen containing heterocyclic ring
US5807872A (en) * 1992-12-16 1998-09-15 Schering Corporation Imidazoylalkyl substituted with a six membered nitrogen containing heterocyclic ring
AU665604B2 (en) * 1991-12-18 1996-01-11 Schering Corporation Imidazoylalkyl substituted with a six membered nitrogen containing heterocyclic ring
FI92843C (fi) * 1993-02-25 1995-01-10 Eija Anitta Maeensivu Uusi menetelmä optisesti aktiivisten glyserolijohdannaisten valmistamiseksi
ATE234290T1 (de) * 1993-11-15 2003-03-15 Schering Corp Phenylalkyl-imidazole als h3-rezeptor- antagonisten
FR2732017B1 (fr) * 1995-03-21 2000-09-22 Inst Nat Sante Rech Med Nouveaux derives de l'imidazole antagonistes et/ou agonistes du recepteur h3 de l'histamine, leur preparation et leurs applications therapeutiques
EP0841923B1 (de) * 1995-06-07 2002-09-18 Gliatech, Inc. 1h-4(5)-substituierte imidazolderivate.

Also Published As

Publication number Publication date
ATE284398T1 (de) 2004-12-15
DE69922528T2 (de) 2005-12-15
EP1121354A1 (de) 2001-08-08
AU1092800A (en) 2000-05-08
ES2229782T3 (es) 2005-04-16
WO2000023438A1 (en) 2000-04-27
CN1198817C (zh) 2005-04-27
CN1323302A (zh) 2001-11-21
CA2346436A1 (en) 2000-04-27
US6133291A (en) 2000-10-17
EP1121354B1 (de) 2004-12-08
JP2002527513A (ja) 2002-08-27

Similar Documents

Publication Publication Date Title
DE69922528D1 (de) N-imidazolyl-alkyl substituierte cyklische amine als histamin-h3 agonisten oder antagonisten
CR9304A (es) Antagonistas del receptor de glucagon, preparaciones y usos terapeuticos
DK1735278T3 (da) Histamin H3-receptormidler, fremstilling og terapeutiske anvendelser
DK1957484T3 (da) Glucagon-receptorantagonister, fremstilling og terapeutiske anvendelser
WO2002076925A3 (en) Non-imidazole aryl alkylamines compounds as histamine h3 receptor antagonists, preparation and therapeutic uses
MXPA04000707A (es) Nuevos antagonistas del receptor y5 del neuropeptido y referencia cruzada a solicitudes relacionadas.
ATE556060T1 (de) Monocyclische anilidspirohydantoine als cgrp- rezeptorantagonisten
EA200700097A1 (ru) Производные хиназолин-4-илпиперидина и циннолин-4-илпиперидина в качестве ингибиторов pde10 для лечения расстройств цнс
ECSP066474A (es) Arilindenopiridinas y arilindenopirimidinas y su uso como antagonista del receptor adenosina a2a
EA200300441A1 (ru) Ассоциация антагониста рецептора св1 и сибутрамина, содержащие их фармацевтические композиции и их применение для лечения ожирения
DE60222396D1 (de) N-(2-arylethyl) benzylamine als 5-ht6 rezeptor-antagoniste
ATE518852T1 (de) Tricyclische anilid-spirohydantoin-cgrp- rezeptorantagonisten
ATE321047T1 (de) Tricyclische diazepine als tocolytische oxytocin rezeptor antagonisten
DK1951659T3 (da) Glucagonreceptorantagonister, fremstilling og terapeutisk anvendelse heraf
DE602005027870D1 (de) Cgrp-rezeptorantagonisten
CY1109694T1 (el) Παραγωγα πυρρολιδινης ως ανταγωνιστες υποδοχεα η3 ισταμινης
PT1497292E (pt) Derivados de azaindolilpiperidina como agentes anti-histaminicos e antialergicos
ATE279923T1 (de) Urotensin-ii rezeptorantagonisten
MY117975A (en) Substituted imidazoles as dual histamine h1 and h3 agonists or antagonists
WO2002044141A3 (en) Substituted imidazoles as dual histamine h1 and h3 agonists or antagonists
BRPI0409958A (pt) quinolinas de benzofuranil- e benzotienil-piperazinil quinolinas e métodos para o seu uso
SE0001373D0 (sv) NPY Y1 receptor agonists and antagonists
MY120281A (en) Substituted imidazoles as dual histamine h1 and h3 agonists or antagonists
MY129677A (en) Substituted imidazoles as dual histamine h1 and h3 agonists or antagonists
DK1668027T3 (da) Cykliske peptider, der virker som urotensin-II antagonister

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee